Loading fund overlap…
22 of 127 unique stocks in common · Jaccard: 17.3%
A weighted portfolio overlap of 48.97% indicates a moderate overlap (a meaningful shared core). This means that out of every ₹100 you invest across these two schemes, approximately ₹48.97 is allocated to the exact same companies at the same relative proportions. The schemes share 22 common holdings.
The largest overlapping asset in their portfolios is Sun Pharmaceutical Industries, which commands a weight of 13.91% in Back to Index and 10.61% in Lic Mf Healthcare Fund. Holding both schemes increases your concentration in Sun Pharmaceutical Industries rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in Back | in Lic |
|---|---|---|
| Sun Pharmaceutical IndustriesPharmaceuticals & Biotechnology | 13.91% | 10.61% |
| Divi's LaboratoriesPharmaceuticals & Biotechnology | 5.90% | 7.56% |
| Apollo Hospitals EnterpriseHealthcare Services | 5.55% | 6.63% |
| Fortis HealthcareHealthcare Services | 3.43% | 4.49% |
| Torrent PharmaceuticalsPharmaceuticals & Biotechnology | 3.03% | 6.51% |
| Aurobindo PharmaPharmaceuticals & Biotechnology | 2.76% | 4.98% |
| Glenmark PharmaceuticalsPharmaceuticals & Biotechnology | 2.56% | 3.07% |
| BioconPharmaceuticals & Biotechnology | 1.87% | 3.06% |
| Max Healthcare InstituteHealthcare Services | 5.23% | 1.82% |
| Mankind PharmaPharmaceuticals & Biotechnology | 1.78% | 2.29% |
| Zydus LifesciencesPharmaceuticals & Biotechnology | 1.60% | 3.15% |
| IPCA LaboratoriesPharmaceuticals & Biotechnology | 1.52% | 2.85% |
| Aster DM HealthcareHealthcare Services | 1.32% | 3.07% |
| Gland PharmaPharmaceuticals & Biotechnology | 0.99% | 3.55% |
| Acutaas ChemicalsPharmaceuticals & Biotechnology | 0.95% | 2.22% |
| Neuland LaboratoriesPharmaceuticals & Biotechnology | 0.92% | 5.49% |
| Onesource Specialty PharmaPharmaceuticals & Biotechnology | 0.68% | 3.08% |
| Global HealthHealthcare Services | 0.66% | 2.97% |
| Metropolis HealthcareHealthcare Services | 0.36% | 2.95% |
| Anthem BiosciencesPharmaceuticals & Biotechnology | 0.33% | 2.16% |
| Dr Agarwal's Health CareHealthcare Services | 0.24% | 2.15% |
| Artemis Medicare ServicesHealthcare Services | 0.09% | 2.87% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on May 2026). Equity holdings only, ISIN-verified. Not investment advice.